TD Waterhouse Canada’s Skye Bioscience SKYE Stock Holding History

TD Waterhouse Canada’s Portfolio SKYE Stock Details SKYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51	Buy	79 +54	+216%	+$44	﹤0.01%	2254
2025 Q4	$18	Hold	25	–	–	﹤0.01%	2017
2025 Q3	$107	Hold	25	–	–	﹤0.01%	1992
2025 Q2	$93	Hold	25	–	–	﹤0.01%	1916
2025 Q1	$35	Hold	25	–	–	﹤0.01%	1898
2024 Q4	$71	Buy	25 +23	+1,150%	+$96	﹤0.01%	1902
2024 Q3	$7	Hold	2	–	–	﹤0.01%	1886
2024 Q2	$16	Buy	+2	New	+$24	﹤0.01%	1893

Other funds holding SKYE

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TD Waterhouse Canada's SKYE Position: Q1 2026 in Review

TD Waterhouse Canada increased its Skye Bioscience (SKYE) stake by 216% in Q1 2026, buying an estimated $44 and bringing the position to 79 shares worth $51. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

TD Waterhouse Canada first reported a position in SKYE in Q2 2024 and has held it in 8 quarters since. The position peaked at $107 in Q3 2025. 39 funds tracked by Wall St. Rank hold SKYE as of Q1 2026.

TD Waterhouse Canada held 79 shares of Skye Bioscience worth $51 as of Q1 2026.
TD Waterhouse Canada bought 54 Skye Bioscience shares in Q1 2026, an estimated $44.
Skye Bioscience made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2254 holding.
TD Waterhouse Canada first reported a position in Skye Bioscience in Q2 2024 and has held it in 8 quarters since.
TD Waterhouse Canada's Skye Bioscience position peaked at $107 in Q3 2025.
39 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.